Literature DB >> 16987057

Serological profiles after consecutive experimental infections of pigs with European H1N1, H3N2, and H1N2 swine influenza viruses.

Kristien Van Reeth1, Geoffrey Labarque, Maurice Pensaert.   

Abstract

Swine influenza viruses (SIVs) of H1N1, H3N2, and H1N2 subtypes, with antigenically different hemagglutinins, are currently cocirculating in pigs in Europe. This study aimed to determine whether the hemagglutination inhibition (HI) test, which is the primary serological test for SIV, is sufficiently specific to discriminate between infections with the three subtypes. In experiment 1, pigs were consecutively inoculated with European H1N1, H3N2, and H1N2 SIVs by the intranasal route, or with the respective subtypes only. In a second experiment, a commercial, inactivated H1N1- and H3N2- based SIV vaccine was administered once to pigs previously infected with one to three SIV subtypes or to influenza-naive pigs. Sequential serum samples were examined in HI and virus-neutralizing (VN) tests to the three strains used for pig inoculations. Of the 160 sera collected after infection with one or two SIV subtypes, only 8 showed cross-reactive antibodies to the remaining subtype(s) in the HI test, and 11 in the VN test. Consecutive inoculations with H1N1 and H1N2 or vice versa were followed by a significant rise in preexisting antibody titers to the first subtype after the second inoculation. When dually infection-immune pigs were inoculated with the third, remaining SIV subtype, nasal virus excretion was undetectable or reduced and the serological response was absent to moderate. A single vaccination of infection-immune pigs resulted in a dramatic rise in HI and VN antibody titers to any of the previously encountered subtypes, whereas SIV-naive pigs barely seroconverted. Most important, pigs previously infected with H1N1 but not with H1N2 developed crossreactive antibodies to H1N2 after the vaccination. In conclusion, the HI test remains adequate for the differential diagnosis of infections with H1N1, H3N2, and H1N2 in European swine populations if it is properly used and if the SIV vaccination status is taken into account.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987057     DOI: 10.1089/vim.2006.19.373

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  25 in total

1.  Inferring patterns of influenza transmission in swine from multiple streams of surveillance data.

Authors:  Christopher C Strelioff; Dhanasekaran Vijaykrishna; Steven Riley; Yi Guan; J S Malik Peiris; James O Lloyd-Smith
Journal:  Proc Biol Sci       Date:  2013-05-08       Impact factor: 5.349

2.  Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses.

Authors:  Eugenio J Abente; Daniela S Rajao; Jefferson Santos; Bryan S Kaplan; Tracy L Nicholson; Susan L Brockmeier; Phillip C Gauger; Daniel R Perez; Amy L Vincent
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

3.  Dynamics of influenza A virus infections in permanently infected pig farms: evidence of recurrent infections, circulation of several swine influenza viruses and reassortment events.

Authors:  Nicolas Rose; Séverine Hervé; Eric Eveno; Nicolas Barbier; Florent Eono; Virginie Dorenlor; Mathieu Andraud; Claire Camsusou; François Madec; Gaëlle Simon
Journal:  Vet Res       Date:  2013-09-04       Impact factor: 3.683

4.  Cross-protection between antigenically distinct H1N1 swine influenza viruses from Europe and North America.

Authors:  Annebel R De Vleeschauwer; Sjouke G Van Poucke; Alexander I Karasin; Christopher W Olsen; Kristien Van Reeth
Journal:  Influenza Other Respir Viruses       Date:  2010-08-17       Impact factor: 4.380

5.  Serologic evidence of human influenza virus infections in swine populations, Cambodia.

Authors:  Sareth Rith; Punnaporn Netrabukkana; San Sorn; Elizabeth Mumford; Channa Mey; Davun Holl; Flavie Goutard; Bunthin Y; Stan Fenwick; Ian Robertson; François Roger; Philippe Buchy
Journal:  Influenza Other Respir Viruses       Date:  2012-05-30       Impact factor: 4.380

6.  Serologic cross-reactivity with pandemic (H1N1) 2009 virus in pigs, Europe.

Authors:  Constantinos S Kyriakis; Christopher W Olsen; Susy Carman; Ian H Brown; Sharon M Brookes; Jan Van Doorsselaere; Kristien Van Reeth
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

7.  Efficacy of influenza vaccination and tamiflu® treatment--comparative studies with Eurasian Swine influenza viruses in pigs.

Authors:  Ralf Duerrwald; Michael Schlegel; Katja Bauer; Théophile Vissiennon; Peter Wutzler; Michaela Schmidtke
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

Review 8.  Optimal Use of Vaccines for Control of Influenza A Virus in Swine.

Authors:  Matthew R Sandbulte; Anna R Spickler; Pamela K Zaabel; James A Roth
Journal:  Vaccines (Basel)       Date:  2015-01-30

9.  Genetic and biological characterisation of an avian-like H1N2 swine influenza virus generated by reassortment of circulating avian-like H1N1 and H3N2 subtypes in Denmark.

Authors:  Ramona Trebbien; Karoline Bragstad; Lars Erik Larsen; Jens Nielsen; Anette Bøtner; Peter M H Heegaard; Anders Fomsgaard; Birgitte Viuff; Charlotte Kristiane Hjulsager
Journal:  Virol J       Date:  2013-09-18       Impact factor: 4.099

10.  Seroprevalence of H1N1, H3N2 and H1N2 influenza viruses in pigs in seven European countries in 2002-2003.

Authors:  Kristien Van Reeth; Ian H Brown; Ralf Dürrwald; Emanuela Foni; Geoffrey Labarque; Patrick Lenihan; Jaime Maldonado; Iwona Markowska-Daniel; Maurice Pensaert; Zdenek Pospisil; Guus Koch
Journal:  Influenza Other Respir Viruses       Date:  2008-05       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.